Cointime

CartilaGen

company

About

CartilaGen is a startup focusing on developing drug-eluting bioactive materials to treat articular cartilage damage and osteoarthritis.

  • 1 - 10

Highlights

Funding Rounds
1
Investors
1

Details

Last Funding Type
Grant
Industries
Biotechnology,Health Care
Founded date
Sep 8, 2015
Number Of Employee
1 - 10
Operating Status
Active

CartilaGen is a biotechnology startup focusing on developing drug-eluting bioactive materials to treat articular cartilage damage and osteoarthritis.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
—
CartilaGen has raised a total of — in funding over 2 rounds. Their latest funding was raised on Feb 23, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 23, 2021 Grant — 1 Iowa G2M Accelerator — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
CartilaGen is funded by 1 investors. Iowa G2M Accelerator are the most recent investors.
Investor Name Lead Investor Funding Round
Iowa G2M Accelerator Yes Grant
Cointime
เนื้อหา
บริษัท